Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Cepharanthine shows promise as a COVID-19 treatment.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Tetracycline can stick to hair follicles and potentially cause hair loss.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

PTH-CBD agonists may help regrow hair after chemotherapy.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Targeting ornithine decarboxylase can help prevent skin cancer.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Imuvert can prevent some chemotherapy-induced hair loss.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.